The Vietnam cancer biomarkers market size reached USD 138.49 Million in 2025. Looking forward, the market is expected to reach USD 343.44 Million by 2034, exhibiting a growth rate (CAGR) of 10.62% during 2026-2034. The market is driven by the increasing prevalence of cancer, the advancement of precision medicine supported by growing healthcare spending, and rising government investment aimed at integrating digital health solutions and enhancing diagnostic technologies. Additionally, the increasing adoption of personalized treatment approaches and biomarker-based diagnostics is expanding the Vietnam cancer biomarkers market share.
|
Report Attribute
|
Key Statistics
|
|---|---|
|
Base Year
|
2025
|
|
Forecast Years
|
2026-2034
|
|
Historical Years
|
2020-2025
|
| Market Size in 2025 | USD 138.49 Million |
| Market Forecast in 2034 | USD 343.44 Million |
| Market Growth Rate 2026-2034 | 10.62% |
Rising Cancer Incidence and Healthcare Infrastructure Development
Vietnam's cancer biomarkers industry is also growing strongly, underpinned by the country's rising cancer burden and associated healthcare infrastructure growth. Population aging, urbanization, also lifestyle shift are factors in cancer incidence rising across a variety of cancer types. To meet the demands of the expanding patient pool, healthcare facilities are increasing diagnostic capacity, specifically emphasizing early detection as well as precision medicine strategies. The government's promise towards enhancing cancer care facilities involves investments in high-tech laboratory facilities, specialized oncology units, and nationwide cancer registries. Medical facilities are increasingly turning to advanced biomarker testing protocols to improve diagnostic sensitivity and treatment planning. Research partnerships between Vietnamese medical facilities and international institutions are enhancing knowledge and technology transfer for cancer biomarker utilization. These developments are creating substantial demand for various biomarker technologies, from traditional protein-based assays to advanced genomic profiling platforms.
Precision Medicine and Personalized Cancer Treatment Advancement
The evolution toward precision medicine represents a transformative trend in Vietnam's cancer biomarkers market, with healthcare providers increasingly recognizing the value of personalized treatment approaches. This shift encompasses the adoption of molecular profiling techniques that enable clinicians to select optimal therapies based on individual patient characteristics and tumor biology. Vietnamese oncologists are implementing biomarker-guided treatment protocols that improve therapeutic outcomes while reducing adverse effects and healthcare costs. The integration of companion diagnostics with targeted therapies is becoming standard practice in major medical centers, particularly for breast cancer, lung cancer, and colorectal cancer management. Academic medical centers are establishing molecular tumor boards that review biomarker testing results to guide treatment decisions for complex cases. The development of local expertise in interpreting genomic and proteomic data is enhancing the clinical utility of biomarker testing. Healthcare providers are investing in bioinformatics infrastructure to support the analysis and interpretation of complex molecular data generated through biomarker testing. Training programs for laboratory personnel and clinicians are expanding to build capacity in precision oncology approaches. The increasing acceptance of biomarker-guided therapy among patients and healthcare providers is driving market expansion across various cancer types and treatment settings.
Government Healthcare Investment and Digital Health Integration
Vietnam's substantial healthcare investment program is significantly impacting the Vietnam cancer biomarkers market growth through enhanced funding for advanced diagnostic technologies and digital health initiatives. The government's strategic focus on healthcare modernization includes specific allocations for cancer care improvement, laboratory infrastructure development, and medical technology acquisition. Digital health integration is transforming biomarker testing workflows through electronic health records, laboratory information systems, and telemedicine platforms that facilitate remote consultation and result interpretation. Public-private partnerships are emerging to accelerate the adoption of innovative biomarker technologies and improve access to advanced diagnostic services across different regions. Healthcare policy reforms are streamlining regulatory approval processes for new biomarker tests while maintaining rigorous quality standards. The national health insurance system is expanding coverage for biomarker testing, making these advanced diagnostics more accessible to a broader patient population. Investment in medical education and research infrastructure is supporting the development of local expertise in cancer biomarker applications. International collaborations facilitated by government initiatives are bringing cutting-edge biomarker technologies and best practices to Vietnamese healthcare institutions.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2026-2034. Our report has categorized the market based on profiling technology, biomolecule, cancer type, application, and end user.
Profiling Technology Insights:
The report has provided a detailed breakup and analysis of the market by profiling technology. This includes omic technologies, imaging technologies, immunoassays, and cytogenetics.
Biomolecule Insights:
A detailed breakup and analysis of the market based on biomolecule have also been provided in the report. This includes genetic biomarkers, protein biomarkers, and glyco-biomarkers.
Cancer Type Insights:
The report has also provided a comprehensive analysis of the market based on cancer type. This includes breast cancer, lung cancer, colorectal cancer, prostate cancer, stomach cancer, and others.
Application Insights:
A detailed breakup and analysis of the market based on application have also been provided in the report. This includes diagnostics, prognostics, risk assessment, drug discovery and development, and others.
End User Insights:
The report has provided a detailed breakup and analysis of the market based on end user. This includes hospitals, academic and research institutions, ambulatory surgical centers, diagnostic laboratories, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Northern Vietnam, Central Vietnam, and Southern Vietnam.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant, has been covered in the report. Also, detailed profiles of all major companies have been provided.
| Report Features | Details |
|---|---|
| Base Year of the Analysis | 2025 |
| Historical Period | 2020-2025 |
| Forecast Period | 2026-2034 |
| Units | Million USD |
| Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
| Profiling Technologies Covered | Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetic |
| Biomolecules Covered | Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers |
| Cancer Types Covered | Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer,Others |
| Applications Covered | Diagnostics, Prognostics, Risk Assessment, Drug Discovery and Development,Others |
| End Users Covered | Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, Others |
| Regions Covered | Northern Vietnam, Central Vietnam, Southern Vietnam |
| Customization Scope | 10% Free Customization |
| Post-Sale Analyst Support | 10-12 Weeks |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: